Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by qwerty22


T.TH

RE:RE:RE:PDC deal

One thing I wonder is just how much they are sparing healthy cells with this...

November 2, 2022

T.TH

RE:RE:PDC deal

I always tend to think that Complete Responses are hard to ignore in these...

November 2, 2022

T.TH

RE:RE:RE:RE:RE:Official termination of distribution rights in Europe

It's crazy. If they make a positive forward looking statements and it...

November 1, 2022

T.TH

RE:RE:Official termination of distribution rights in Europe

"Taimed Biologics Says" Nothing to do with them. Biobob...

November 1, 2022

V.RHT.H

RE:RE:RE:RE:I call BS.

I don't think weekend news is the right way to do this. You can't...

November 1, 2022

T.TH

Money money money

Dai­ichi Sankyo sets new highs for As­traZeneca-part­nered can...

October 31, 2022

V.RHT.H

RE:RE:RE:RE:RE:RE:RE:I call BS.

"Above-average" for a "thinly traded stock" can certainly...

October 31, 2022

V.RHT.H

RE:RE:I call BS.

I thought about this also. It might be true, it would explain why they waited...

October 31, 2022

T.TH

RE:A clearer roadmap for TH-1902 please

Yep I know. Imagine being an ESSA investor. Trials are the life blood of...

October 31, 2022

V.RHT.H

RE:RESULTS

If only there was a way for them to communicate that to us...

October 31, 2022

T.TH

RE:RE:RE:RE:RE:RE:A concern?

On point 1 I thought the same as you for a long time but Christian said this...

October 31, 2022

V.RHT.H

RE:RE:RE:RE:RE:I call BS.

I wouldn't consider the CAN vol high (<$150,000 worth traded). I also...

October 31, 2022

T.TH

RE:RE:RE:RE:A concern?

IDK what people are calling Ph1 and Ph2 but I see the path forward as 10...

October 31, 2022

V.RHT.H

RE:RE:I call BS.

The angel on my left shoulder says If you give them the benefit of the doubt...

October 31, 2022

V.RHT.H

RE:RE:papi waiting for your answers

it's the complete opposite to what the market needs from them...

October 31, 2022

V.RHT.H

RE:RE:RHT DELAY EARNING RELEASE. NO NEW DATE ANNOUNCED

Building trust with the market, way to go. I said this wouldn't be bad...

October 31, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:Principal investigator for TH1902

I know I got your point. Personally I like Shah, he seems enthusiastic about...

October 30, 2022

T.TH

RE:RE:RE:RE:RE:RE:Principal investigator for TH1902

"The PH measurement can be done in vivo or ex vivo" Sorry I...

October 30, 2022

T.TH

RE:RE:RE:RE:RE:Principal investigator for TH1902

I don't think evaluable is how you are defining it. In a well run trial...

October 30, 2022

T.TH

RE:RE:RE:RE:Principal investigator for TH1902

I don't see any pre-screening here. I don't think it's...

October 30, 2022

Featured Company